-
EDITORIAL
Catalysis as a Key Technology for the Development and Implementation of Cost-Competitive and Sustainable Production of Active Pharmaceutical Ingredients (APIs)
W. Cabri, A. Tolomelli
-
CATALYSIS
One catalyst to rule them all: a journey from bulk to atom-level control
V. Barbera, A. Ravicini, D. Allevi
-
CATALYSIS
Biocatalysis in the pharmaceutical industry: beyond sustainability, towards efficiency
A. Ricci
-
CATALYSIS
Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs
M. Baudino, L. Pontini, C. Portolani1, G. Cerai, J. Roletto
-
CATALYSIS
Towards better biocatalysts: advances in high throughput screening and data-driven design of immobilized enzymes
D. Padrosa
-
SUSTAINABILITY
Deep eutectic systems – bio-based solvents designed with natural molecules
A. C. Duarte, A. Burke
-
SUSTAINABILITY
The impact of platinum group metal catalysts in fine chemical synthesis
S. Facchetti
-
ARTIFICIAL INTELLIGENCE
Digital adoption platforms: could just-in-time learning prompts be the answer to consistent, high-quality data as pharma companies refresh systems to support GxP processes?
S. Gölden
-
DRUG DISCOVERY
Unlocking the GPCR puzzle: how AI is tackling drug discovery’s most elusive targets
M. Tunaboylu
-
PHARMACOVIGILANCE
Rethinking the logistics of pharmacovigilance: why current approaches to in-country literature monitoring are unsustainable
N. Baker
-
DELIVERY INNOVATIONS
Ophthalmic Drug Delivery Latest Development
B. Quaglia
